This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels
EU Pharmaceutical Law Forum 2024
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels

Wednesday 22 May 2024

Stay at the Forefront of Key Developments in Real World Consequences of Regulatory Policy

Leave with Practical Legal Guidance from the Highest Flyers at the EU Commission & EMA, Including Specialist Expertise from a European Parliament Rapporteur

Benchmark Your Regulatory Legal Progress With Real World Insights On Key Pharmaceutical Legal Issues:

Real World Consequences of Regulatory Policy

  • Exclusive Rapporteur’s analysis into the EU pharmaceutical legislation revision
  • Impact of revisions on Europe's competitiveness and investment landscape
  • Developments to incentive schemes and the regulatory challenges

How can Pharmaceutical Companies Protect their Rights?

  • Analysis of business risks posed by Leadiant Case
  • Enforcement of market exclusivity: What measures can originators take?
  • Price transparency scrutiny: Recent decisions and legal concerns

Latest Advances in Regulatory Frameworks

  • Frameworks, guidance and risks of decentralized clinical trials
  • Developments for the AI Act and EMA approach to AI
  • Managing the conflict of IVDR with the EU CTR for companion diagnostics